Advanced Medical Solutions Group (LON:AMS) Stock Passes Above 200 Day Moving Average - Time to Sell?

Key Points

• Advanced Medical Solutions Group stock has recently surpassed its 200-day moving average, trading as high as GBX 209 ($2.81), indicating potential bullish momentum.
• Analysts maintain a positive outlook on the stock, with Deutsche Bank and Berenberg Bank issuing "buy" ratings and target prices of GBX 275 and GBX 300, respectively.
• The company boasts a market cap of £448.38 million and has a favorable liquidity standing, indicated by a current ratio of 8.39 and a quick ratio of 4.58.

Shares of Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 203.75 ($2.74) and traded as high as GBX 209 ($2.81). Advanced Medical Solutions Group shares last traded at GBX 206.50 ($2.78), with a volume of 533,194 shares traded.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 275 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, July 16th. Berenberg Bank reissued a "buy" rating and set a GBX 300 price objective on shares of Advanced Medical Solutions Group in a report on Tuesday, July 15th. Two equities research analysts have rated the stock with a Buy rating, According to MarketBeat, Advanced Medical Solutions Group currently has an average rating of "Buy" and a consensus target price of GBX 287.50.

Advanced Medical Solutions Group Trading Up 0.5%

The stock has a market cap of £448.38 million, a PE ratio of 6,384.62, a P/E/G ratio of 5.00 and a beta of 0.74. The firm has a 50-day simple moving average of GBX 205.46 and a 200-day simple moving average of GBX 203.75. The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.